Evidence map›Paper›PMID 26084409›Full record

ArticleThe Journal of physiology2015

The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938.

Azucena Perez-Burgos, Lu Wang, Karen-Anne McVey Neufeld, Yu-Kang Mao, Mustafa Ahmadzai, Luke J Janssen, Andrew M Stanisz, John Bienenstock, Wolfgang A Kunze

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it, 122 citations in OpenAlex.

  1. Efficacy and Safety ofNutrients · 2026
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Microbiome: A Key Regulator of Body-Brain Interactions.Advances in experimental medicine and biology · 2025
    Review
  9. Review
  10. Review
  11. Underneath the Gut-Brain Axis in IBD-Evidence of the Non-Obvious.International journal of molecular sciences · 2024
    Review
  12. Review
  13. Applied and environmental microbiology · 2024
    Article
  14. The Gut Microbiota and Chronic Pain.Current pain and headache reports · 2024
    Review
  15. Review
  16. Review
  17. Probiotics in Functional Gastrointestinal Disorders.Advances in experimental medicine and biology · 2024
    Review
  18. Probiotics in Postoperative Pain Management.Journal of personalized medicine · 2023
    Review
  19. Review
  20. Frontiers in gastroenterology (Lausanne, Switzerland) · 2023
    Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Azucena Perez-BurgosMcMaster Brain-Body Institute, St Joseph's Healthcare, Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, Canada, L8N 4A6.
Lu WangFarncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
Karen-Anne McVey NeufeldMcMaster Brain-Body Institute, St Joseph's Healthcare, Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, Canada, L8N 4A6.
Yu-Kang MaoMcMaster Brain-Body Institute, St Joseph's Healthcare, Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, Canada, L8N 4A6.
Mustafa AhmadzaiFirestone Institute for Respiratory Health, St Joseph's Hospital, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Luke J JanssenFirestone Institute for Respiratory Health, St Joseph's Hospital, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Andrew M StaniszMcMaster Brain-Body Institute, St Joseph's Healthcare, Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, Canada, L8N 4A6.
John BienenstockMcMaster Brain-Body Institute, St Joseph's Healthcare, Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, Canada, L8N 4A6.
Wolfgang A KunzeMcMaster Brain-Body Institute, St Joseph's Healthcare, Hamilton, 50 Charlton Avenue East, Hamilton, Ontario, Canada, L8N 4A6.
St. Joseph’s Healthcare Hamilton · CAInstitute for Respiratory Health · AUMcMaster University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Certain probiotic bacteria have been shown to reduce distension-dependent gut pain, but the mechanisms involved remain obscure. Live luminal Lactobacillus reuteri (DSM 17938) and its conditioned medium dose dependently reduced jejunal spinal nerve firing evoked by distension or capsaicin, and 80% of this response was blocked by a specific TRPV1 channel antagonist or in TRPV1 knockout mice. The specificity of DSM action on TRPV1 was further confirmed by its inhibition of capsaicin-induced intracellular calcium increases in dorsal root ganglion neurons. Another lactobacillus with ability to reduce gut pain did not modify this response. Prior feeding of rats with DSM inhibited the bradycardia induced by painful gastric distension. These results offer a system for the screening of new and improved candidate bacteria that may be useful as novel therapeutic adjuncts in gut pain. Certain bacteria exert visceral antinociceptive activity, but the mechanisms involved are not determined. Lactobacillus reuteri DSM 17938 was examined since it may be antinociceptive in children. Since transient receptor potential vanilloid 1 (TRPV1) channel activity may mediate nociceptive signals, we hypothesized that TRPV1 current is inhibited by DSM. We tested this by examining the effect of DSM on the firing frequency of spinal nerve fibres in murine jejunal mesenteric nerve bundles following serosal application of capsaicin. We also measured the effects of DSM on capsaicin-evoked increase in intracellular Ca(2+) or ionic current in dorsal root ganglion (DRG) neurons. Furthermore, we tested the in vivo antinociceptive effects of oral DSM on gastric distension in rats. Live DSM reduced the response of capsaicin- and distension-evoked firing of spinal nerve action potentials (238 ± 27.5% vs. 129 ± 17%). DSM also reduced the capsaicin-evoked TRPV1 ionic current in DRG neuronal primary culture from 83 ± 11% to 41 ± 8% of the initial response to capsaicin only. Another lactobacillus (Lactobacillus rhamnosus JB-1) with known visceral anti-nociceptive activity did not have these effects. DSM also inhibited capsaicin-evoked Ca(2+) increase in DRG neurons; an increase in Ca(2+) fluorescence intensity ratio of 2.36 ± 0.31 evoked by capsaicin was reduced to 1.25 ± 0.04. DSM releasable products (conditioned medium) mimicked DSM inhibition of capsaicin-evoked excitability. The TRPV1 antagonist 6-iodonordihydrocapsaicin or the use of TRPV1 knock-out mice revealed that TRPV1 channels mediate about 80% of the inhibitory effect of DSM on mesenteric nerve response to high intensity gut distension. Finally, feeding with DSM inhibited perception in rats of painful gastric distension. Our results identify a specific target channel for a probiotic with potential therapeutic properties.

Indexed as

Limosilactobacillus reuteriProbioticsAnalgesiaAnimalsBradycardiaCapsaicinGanglia, SpinalJejunumMaleMesenteryMice, KnockoutRats, Sprague-DawleySpinal NervesStomach DiseasesTRPV Cation ChannelsCapsaicinTRPV1 receptorTRPV Cation Channels

Identifiers

PMID26084409
PMCPMC4575579
OpenAlexW2145865202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.